CC

Checkpoint Capital Portfolio holdings

AUM $215M
1-Year Est. Return 27.24%
This Quarter Est. Return
1 Year Est. Return
+27.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$215M
AUM Growth
+$32.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
14
New
Increased
Reduced
Closed

Top Buys

1
+$24.9M
2
+$19.3M
3
+$9.65M
4
IRON icon
Disc Medicine
IRON
+$1.15M

Top Sells

1
+$12.4M
2
+$5.19M
3
+$4.86M
4
RVMD icon
Revolution Medicines
RVMD
+$4.12M
5
TCRX icon
TScan Therapeutics
TCRX
+$2.78M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGX icon
1
argenx
ARGX
$50.4B
$82.7M 38.52%
149,977
+34,977
RYTM icon
2
Rhythm Pharmaceuticals
RYTM
$7.56B
$67M 31.21%
1,060,000
+152,760
CORT icon
3
Corcept Therapeutics
CORT
$7.74B
$25.2M 11.76%
343,917
+338,917
IRON icon
4
Disc Medicine
IRON
$3.22B
$14M 6.54%
265,000
+21,689
RVMD icon
5
Revolution Medicines
RVMD
$11B
$10.3M 4.8%
280,000
-112,011
SEPN
6
Septerna Inc
SEPN
$918M
$6.2M 2.89%
586,473
-238,405
KYMR icon
7
Kymera Therapeutics
KYMR
$4.42B
$4.67M 2.18%
106,991
-29,614
PTGX icon
8
Protagonist Therapeutics
PTGX
$4.89B
$4.49M 2.09%
81,311
-93,873
CDTX icon
9
Cidara Therapeutics
CDTX
$2.77B
– –
-104,380
IMCR icon
10
Immunocore
IMCR
$1.67B
– –
-9,011
RAPT icon
11
RAPT Therapeutics
RAPT
$751M
– –
-13,729
SLNO icon
12
Soleno Therapeutics
SLNO
$3.57B
– –
-172,902
STOK icon
13
Stoke Therapeutics
STOK
$1.65B
– –
-730,717
TCRX icon
14
TScan Therapeutics
TCRX
$110M
– –
-2,017,650